Timothy P. Walbert
Net Worth

Last updated:

What is Timothy P. Walbert net worth?

The estimated net worth of Mr. Timothy P. Walbert is at least $212,334,195 as of 5 Jan 2023. He has earned $141,094,195 from insider trading and has received compensation worth at least $71,240,000 in Horizon Therapeutics Public Limited Company.

What is the salary of Timothy P. Walbert?

Mr. Timothy P. Walbert salary is $5,480,000 per year as Chairman, Pres & Chief Executive Officer in Horizon Therapeutics Public Limited Company.

How old is Timothy P. Walbert?

Mr. Timothy P. Walbert is 58 years old, born in 1967.

What stocks does Timothy P. Walbert currently own?

As insider, Mr. Timothy P. Walbert owns shares in one company:

Company Title Shares Price per share Total value
Horizon Therapeutics Public Limited Company (HZNP) Chairman, Pres & Chief Executive Officer 435,826 $0 $0

What does Horizon Therapeutics Public Limited Company do?

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.

Timothy P. Walbert insider trading

Horizon Therapeutics Public Limited Company

Mr. Timothy P. Walbert has made 60 insider trades between 2012-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 408,347 units of HZNP stock on 14 Nov 2018. As of 5 Jan 2023 he still owns at least 435,826 units of HZNP stock.

Transaction Date Security Shares Price per share Total value Source
Option
Ordinary Shares 219,995 N/A N/A
Option
Restricted Stock Units (RSUs) 24,598 N/A N/A
Option
Performance Restricted Stock Units (PSUs) 46,400 N/A N/A
Option
Performance Restricted Stock Units (PSUs) 39,944 N/A N/A
Option
Restricted Stock Units (RSUs) 34,928 N/A N/A
Option
Performance Restricted Stock Units (PSUs) 104,498 N/A N/A
Option
Ordinary Shares 104,498 N/A N/A
Option
Restricted Stock Units (RSUs) 4,657 N/A N/A
Option
Restricted Stock Units (RSUs) 7,141 N/A N/A
Option
Restricted Stock Units (RSUs) 3,387 N/A N/A
Option
Ordinary Shares 15,185 N/A N/A
Sale
Ordinary Shares 15,200 $92.08 $1,399,616
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 9,800 $92.74 $908,852
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Sale
Ordinary Shares 18,500 $92.04 $1,702,740
Sale
Ordinary Shares 3,800 $93.21 $354,198
Sale
Ordinary Shares 2,700 $94.46 $255,042
Option
Ordinary Shares 25,000 $22.14 $553,500
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Sale
Ordinary Shares 25,000 $90 $2,250,000
Option
Stock Option (Right to Buy) 17,600 $22.14 $389,664
Option
Ordinary Shares 17,600 $22.14 $389,664
Sale
Ordinary Shares 17,600 $90 $1,584,000
Sale
Ordinary Shares 5,000 $91.11 $455,550
Option
Ordinary Shares 7,400 $22.14 $163,836
Option
Stock Option (Right to Buy) 7,400 $22.14 $163,836
Sale
Ordinary Shares 2,400 $90.33 $216,792
Sale
Ordinary Shares 7,608 $96.62 $735,085
Sale
Ordinary Shares 13,942 $95.38 $1,329,788
Sale
Ordinary Shares 3,450 $97.43 $336,134
Sale
Ordinary Shares 16,413 $106.1 $1,741,419
Sale
Ordinary Shares 1,800 $107.94 $194,292
Sale
Ordinary Shares 1,087 $109.39 $118,907
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Sale
Ordinary Shares 5,700 $107.02 $610,014
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 8,313 $111.7 $928,562
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 16,687 $112.72 $1,880,959
Sale
Ordinary Shares 14,520 $104.61 $1,518,937
Sale
Ordinary Shares 35,480 $105.52 $3,743,850
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 25,000 $109.37 $2,734,350
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 18,338 $100.77 $1,847,920
Sale
Ordinary Shares 6,662 $101.38 $675,394
Sale
Ordinary Shares 19,000 $91.54 $1,739,260
Sale
Ordinary Shares 26,892 $90.41 $2,431,306
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Sale
Ordinary Shares 1,208 $93.57 $113,033
Sale
Ordinary Shares 2,900 $92.5 $268,250
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 25,000 $92.51 $2,312,675
Sale
Ordinary Shares 19,663 $97.32 $1,913,603
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 5,337 $97.74 $521,638
Option
Ordinary Shares 9,087 N/A N/A
Option
Restricted Stock Units (RSUs) 9,087 N/A N/A
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Sale
Ordinary Shares 100,000 $91.77 $9,177,000
Sale
Ordinary Shares 25,000 $90 $2,250,000
Option
Ordinary Shares 25,000 $22.14 $553,500
Option
Ordinary Shares 20,336 N/A N/A
Option
Restricted Stock Units (RSUs) 20,336 N/A N/A
Sale
Ordinary Shares 25,000 $90.02 $2,250,425
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Ordinary Shares 25,000 $22.14 $553,500
Option
Ordinary Shares 249,793 N/A N/A
Option
Restricted Stock Units (RSU) 249,793 N/A N/A
Sale
Ordinary Shares 75,000 $108.29 $8,121,375
Option
Stock Option (Right to Buy) 25,000 $22.14 $553,500
Option
Ordinary Shares 25,000 $22.14 $553,500
Sale
Ordinary Shares 50,000 $102.55 $5,127,350
Sale
Ordinary Shares 25,000 $118.81 $2,970,125
Sale
Ordinary Shares 50,000 $110.92 $5,546,150
Option
Stock Option (Right to Buy) 7,435 $22.14 $164,611
Option
Ordinary Shares 7,435 $22.14 $164,611
Sale
Ordinary Shares 25,000 $102.11 $2,552,750
Sale
Ordinary Shares 25,000 $94.29 $2,357,250
Sale
Ordinary Shares 25,000 N/A N/A
Sale
Ordinary Shares 25,000 $91.61 $2,290,125
Sale
Ordinary Shares 25,000 $91.61 $2,290,125
Sale
Ordinary Shares 25,000 $94.65 $2,366,125
Sale
Ordinary Shares 26,975 $91.63 $2,471,800
Option
Ordinary Shares 9,087 N/A N/A
Option
Restricted Stock Units (RSUs) 9,087 N/A N/A
Sale
Ordinary Shares 11,323 $76.58 $867,081
Option
Performance Restricted Stock Units (PSUs) 22,905 N/A N/A
Option
Ordinary Shares 22,905 N/A N/A
Sale
Ordinary Shares 211,204 $78.21 $16,517,842
Option
Restricted Stock Units (RSU) 272,443 N/A N/A
Option
Ordinary Shares 272,443 N/A N/A
Sale
Ordinary Shares 110,000 $73.31 $8,064,540
Sale
Ordinary Shares 93,864 $35.23 $3,306,829
Option
Ordinary Shares 9,086 N/A N/A
Option
Restricted Stock Units (RSUs) 9,086 N/A N/A
Sale
Ordinary Shares 84,886 $35.57 $3,019,395
Option
Restricted Stock Units (RSU) 211,000 N/A N/A
Option
Ordinary Shares 211,000 N/A N/A
Option
Stock Option (Right to Buy) 107,187 $2.4 $257,249
Sale
Ordinary Shares 320,174 $28.02 $8,970,315
Option
Ordinary Shares 311,869 $5.01 $1,560,904
Sale
Ordinary Shares 2,500 $28 $70,000
Sale
Ordinary Shares 1,984 $28 $55,552
Sale
Ordinary Shares 56,836 $28.01 $1,591,692
Option
Restricted Stock Units 125,000 N/A N/A
Option
Ordinary Shares 125,000 N/A N/A
Option
Restricted Stock Units (RSU) 152,966 N/A N/A
Option
Ordinary Shares 152,966 N/A N/A
Option
Ordinary Shares 49,801 $5.01 $249,254
Option
Stock Option (Right to Buy) 49,801 $5.01 $249,254
Option
Ordinary Shares 408,347 $7.7 $3,144,272
Sale
Ordinary Shares 408,347 $21.54 $8,795,794
Option
Stock Option (Right to Buy) 104,334 $5.2 $542,537
Option
Stock Option (Right to Buy) 83,353 $10.43 $869,372
Sale
Ordinary Shares 83,353 $10.43 $869,372
Option
Ordinary Shares 83,353 $10.43 $869,372
Option
Ordinary Shares 125,000 N/A N/A
Option
Restricted Stock Units 125,000 N/A N/A
Option
Ordinary Shares 49,500 N/A N/A
Option
Restricted Stock Units 49,500 N/A N/A
Option
Restricted Stock Units 125,000 N/A N/A
Option
Ordinary Shares 125,000 N/A N/A
Option
Ordinary Shares 81,675 N/A N/A
Option
Restricted Stock Units 81,675 N/A N/A
Option
Stock Option (Right to Buy) 8,330 $2.4 $19,992
Option
Ordinary Shares 8,330 $2.4 $19,992
Option
Restricted Stock Units 125,000 N/A N/A
Option
Ordinary Shares 125,000 N/A N/A
Option
Restricted Stock Units 81,675 N/A N/A
Option
Ordinary Shares 81,675 N/A N/A
Option
Ordinary Shares 2,082 $4.96 $10,327
Option
Stock Option (Right to Buy) 2,082 $4.96 $10,327
Option
Ordinary Shares 33,211 N/A N/A
Option
Restricted Stock Units 33,211 N/A N/A
Option
Ordinary Shares 86,598 $8.38 $725,951
Option
Stock Option (Right to Buy) 86,598 $8.38 $725,951
Option
Ordinary shares 81,675 N/A N/A
Option
Restricted stock units 81,675 N/A N/A
Option
Restricted Stock Units 33,210 N/A N/A
Option
Ordinary Shares 33,210 N/A N/A
Sale
Ordinary Shares 150,000 $12.05 $1,807,500
Sale
Common stock 31,742 $12.94 $410,741
Option
Common Stock 32,175 N/A N/A
Option
Restricted Stock Units 32,175 N/A N/A
Option
Common Stock 33,210 N/A N/A
Sale
Common Stock 12,124 $6.79 $82,322
Option
Restricted stock units 33,210 N/A N/A
Sale
Common stock 20,749 $2.36 $48,968
Option
Restricted stock units 33,211 N/A N/A
Sale
Common Stock 10,301 $2.28 $23,486
Option
Common Stock 33,211 N/A N/A

Horizon Therapeutics Public Limited Company key executives

Horizon Therapeutics Public Limited Company executives and other stock owners filed with the SEC: